1. Glycaemic management of type 2 diabetes
Balasubramanian T. Srinivasan, Melanie Davies 
Medicine 
Volume 47, Issue 1, Pages (January 2019)
DOI: /j.mpmed
Copyright © Terms and Conditions

2. Figure 1
DPP-4i, dipeptidyl peptidase 4 inhibitor; GLP1RA, glucagon-like peptide 1 receptor agonist; OAA, oral anti-hyperglycaemic agent; SGLT-2i, sodium glucose co-transporter 2 inhibitor; SU, sulfonylurea. Adapted from NICE.3
Medicine  , 32-39DOI: ( /j.mpmed )
Copyright © Terms and Conditions